Epidemiological Study on Community Acquired Pneumonia
ConditionCommunity Acquired Pneumonia
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorCapnetz Stiftung
About this trial
The main objective of this study is to investigate prevalence and risk factors for community-acquired pneumonia (CAP) and its interaction with comorbidities in an unselected group of adult patients receiving outpatient and inpatient care. In addition, information on HIV as a risk factor for CAP and on CAP in immunocompromised patients is collected.
Eligibility criteria
Qualifiers
age ≥ 18
infiltrate on chest X-ray
further Inclusion criteria (at least one must apply): cough or purulent sputum or pathologic lung auscultation (crackles) or fever
Disqualifiers
Hospitalization lasting longer than 48 hours prior to the diagnosis of the current pneumonia
Newly diagnosed, active pulmonary tuberculosis within the last 2 months
Trial design
Treatments tested in this trial
- Not listed
Trial groups
20,000 Participants
are grouped into 3 trial groupsSponsors and collaborators
Capnetz Stiftung
Lead sponsor
Deutsches Zentrum für Lungenforschung e. V.
Collaborator
Source ClinicalTrials.gov